Global Eye Allergy Therapeutics Market 2019-2023

目のアレルギー治療薬の世界市場2019-2023

◆タイトル:Global Eye Allergy Therapeutics Market 2019-2023
◆商品コード:IRTNTR31313
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年5月16日
◆ページ数:140
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:Health Care
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、目のアレルギー治療薬の世界市場について調査・分析し、市場概要、市場環境、目のアレルギー治療薬市場規模、製品別(抗ヒスタミン、肥満細胞安定薬、ステロイド薬、免疫調節薬、その他)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・目のアレルギー治療薬の世界市場概要
・目のアレルギー治療薬の世界市場環境
・目のアレルギー治療薬の世界市場動向
・目のアレルギー治療薬の世界市場規模
・目のアレルギー治療薬の世界市場:業界構造分析
・目のアレルギー治療薬の世界市場:製品別(抗ヒスタミン、肥満細胞安定薬、ステロイド薬、免疫調節薬、その他)
・目のアレルギー治療薬の世界市場:地域別市場規模・分析
・目のアレルギー治療薬の北米市場規模・予測
・目のアレルギー治療薬のヨーロッパ・中東・アフリカ市場規模・予測
・目のアレルギー治療薬のアジア太平洋市場規模・予測
・目のアレルギー治療薬の主要国分析
・目のアレルギー治療薬の世界市場:意思決定フレームワーク
・目のアレルギー治療薬の世界市場:成長要因、課題
・目のアレルギー治療薬の世界市場:競争環境
・目のアレルギー治療薬の世界市場:関連企業情報(ベンダー分析)

About this market

The global eye allergy therapeutics market is currently witnessing a high unmet medical need for a once-daily double-action eye preparation for the treatment of various types of eye allergies. At present, the drugs administered for eye allergies are intended to treat symptoms such as redness and itching, and they provide substantial assistance to patients leaving approximately 20-30% of the patients untreated. Also, the side effects associated with the available therapeutic options limit their use for a long duration. Therefore, the market is currently exhibiting a need for effective multiple-dose therapies that can treat the signs and symptoms of eye allergies with a quick onset of action and without side effects. This is expected to propel the growth of the market during the forecast period. Technavio’s analysts have predicted that the eye allergy therapeutics market will register a CAGR of almost 5% by 2023.

Market Overview

Significant comorbidity associated with eye allergies

All types of eye allergies are associated with chronic symptoms such as ocular itching inflammation redness and watery eyes, which are persistently disturbing, having an adverse effect on patients’ life. This leads to loss of work performance decreased productivity and increased healthcare costs, which can put a significant economic burden on patients. To avoid the substantial comorbidity associated with eye allergies, people spend on the required therapeutics, which will drive the growth of the market during the forecast period.

Lack of awareness

The level of awareness about eye allergies is generally low. Media and the Internet were the primary sources of information for most people. The level of knowledge and awareness regarding eye allergies are low among medical students and was far lower among those with a non-medical background. The lack of awareness of the symptoms associated with eye allergies and the negligence in seeking medical help for their treatment are expected to limit the growth of the market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the eye allergy therapeutics market during 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented. The presence of several companies, including Akorn Inc. and Allergan Plc, the competitive environment is quite intense. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies. Bausch Health Companies Inc., Novartis AG, and Santen Pharmaceutical Co. Ltd. are some of the major companies covered in this report.

【資料の目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: EYE ALLERGY: AN OVERVIEW

PART 07: PIPELINE ANALYSIS

PART 08: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Antihistamines – Market size and forecast 2018-2023

Mast cell stabilizers – Market size and forecast 2018-2023

Corticosteroids – Market size and forecast 2018-2023

Immunomodulators – Market size and forecast 2018-2023

Others – Market size and forecast 2018-2023

Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 15: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Akorn Inc.

Allergan Plc

Bausch Health Companies Inc.

Novartis AG

Santen Pharmaceutical Co. Ltd.

PART 16: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 17: EXPLORE TECHNAVIO

Exhibit 01: Global pharmaceuticals market

Exhibit 02: Segments of global pharmaceuticals market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Facts about eye allergy

Exhibit 18: Pathophysiology of eye allergy

Exhibit 19: Pipeline landscape

Exhibit 20: Some key clinical trials: Eye allergy therapeutics

Exhibit 21: Product – Market share 2018-2023 (%)

Exhibit 22: Comparison by product

Exhibit 23: Antihistamines – Market size and forecast 2018-2023 ($ millions)

Exhibit 24: Classification of antihistamines.

Exhibit 25: Example of antihistamine ophthalmic drops

Exhibit 26: Antihistamines – Year-over-year growth 2019-2023 (%)

Exhibit 27: Mast cell stabilizers – Market size and forecast 2018-2023 ($ millions)

Exhibit 28: Examples of mast cell stabilizer ophthalmic drops

Exhibit 29: Mast cell stabilizers – Year-over-year growth 2019-2023 (%)

Exhibit 30: Corticosteroids – Market size and forecast 2018-2023 ($ millions)

Exhibit 31: Examples of corticosteroid ophthalmic drops

Exhibit 32: Side effects of corticosteroid ophthalmic drops

Exhibit 33: Corticosteroids – Year-over-year growth 2019-2023 (%)

Exhibit 34: Immunomodulators – Market size and forecast 2018-2023 ($ millions)

Exhibit 35: Examples of immunosuppressant ophthalmic drops

Exhibit 36: Immunomodulators – Year-over-year growth 2019-2023 (%)

Exhibit 37: Others – Market size and forecast 2018-2023 ($ millions)

Exhibit 38: Examples of decongestant ophthalmic drops

Exhibit 39: Example of NSAID ophthalmic drops

Exhibit 40: Examples of artificial tears

Exhibit 41: Others – Year-over-year growth 2019-2023 (%)

Exhibit 42: Market opportunity by product

Exhibit 43: Customer landscape

Exhibit 44: Market share by geography 2018-2023 (%)

Exhibit 45: Geographic comparison

Exhibit 46: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 47: ALLEVIATE trial in allergic conjunctivitis patients

Exhibit 48: North America – Year-over-year growth 2019-2023 (%)

Exhibit 49: Top 3 countries in North America

Exhibit 50: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 51: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 52: Top 3 countries in Europe

Exhibit 53: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 54: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 55: Top 3 countries in Asia

Exhibit 56: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 57: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 58: Top 3 countries in ROW

Exhibit 59: Key leading countries

Exhibit 60: Market opportunity

Exhibit 61: Impact of allergy symptoms on professional and personal lives of patients

Exhibit 62: Pharmacologic treatment for allergic conjunctivitis

Exhibit 63: Impact of drivers and challenges

Exhibit 64: Benefits associated with SCIT

Exhibit 65: Risk factors that increase susceptibility to eye allergies

Exhibit 66: Vendor landscape

Exhibit 67: Landscape disruption

Exhibit 68: Vendors covered

Exhibit 69: Vendor classification

Exhibit 70: Market positioning of vendors

Exhibit 71: Akorn Inc. – Vendor overview

Exhibit 72: Akorn Inc. – Business segments

Exhibit 73: Akorn Inc. – Organizational developments

Exhibit 74: Akorn Inc. – Segment focus

Exhibit 75: Akorn Inc. – Key offerings

Exhibit 76: Akorn Inc. – Key customers

Exhibit 77: Allergan Plc – Vendor overview

Exhibit 78: Allergan Plc – Business segments

Exhibit 79: Allergan Plc – Organizational developments

Exhibit 80: Allergan Plc – Geographic focus

Exhibit 81: Allergan Plc – Segment focus

Exhibit 82: Allergan Plc – Key offerings

Exhibit 83: Allergan Plc – Key customers

Exhibit 84: Bausch Health Companies Inc. – Vendor overview

Exhibit 85: Bausch Health Companies Inc. – Business segments

Exhibit 86: Bausch Health Companies Inc. – Organizational developments

Exhibit 87: Bausch Health Companies Inc. – Geographic focus

Exhibit 88: Bausch Health Companies Inc. – Segment focus

Exhibit 89: Bausch Health Companies Inc. – Key offerings

Exhibit 90: Bausch Health Companies Inc. – Key customers

Exhibit 91: Novartis AG – Vendor overview

Exhibit 92: Novartis AG – Business segments

Exhibit 93: Novartis AG – Organizational developments

Exhibit 94: Novartis AG – Geographic focus

Exhibit 95: Novartis AG – Segment focus

Exhibit 96: Novartis AG – Key offerings

Exhibit 97: Novartis AG – Key customers

Exhibit 98: Santen Pharmaceutical Co. Ltd. – Vendor overview

Exhibit 99: Santen Pharmaceutical Co. Ltd. – Business segments

Exhibit 100: Santen Pharmaceutical Co. Ltd. – Organizational developments

Exhibit 101: Santen Pharmaceutical Co. Ltd. – Geographic focus

Exhibit 102: Santen Pharmaceutical Co. Ltd. – Segment focus

Exhibit 103: Santen Pharmaceutical Co. Ltd. – Key offerings

Exhibit 104: Santen Pharmaceutical Co. Ltd. – Key customers

Exhibit 105: Validation techniques employed for market sizing

Exhibit 106: Definition of market positioning of vendors



【掲載企業】

Akorn Inc.、Allergan Plc、Bausch Health Companies Inc.、Novartis AG、Santen Pharmaceutical Co. Ltd.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[目のアレルギー治療薬の世界市場2019-2023]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆